JP2013509376A5 - - Google Patents

Download PDF

Info

Publication number
JP2013509376A5
JP2013509376A5 JP2012535821A JP2012535821A JP2013509376A5 JP 2013509376 A5 JP2013509376 A5 JP 2013509376A5 JP 2012535821 A JP2012535821 A JP 2012535821A JP 2012535821 A JP2012535821 A JP 2012535821A JP 2013509376 A5 JP2013509376 A5 JP 2013509376A5
Authority
JP
Japan
Prior art keywords
phenyl
substituted
amino
propanamide
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012535821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013509376A (ja
Filing date
Publication date
Priority claimed from EP09174390A external-priority patent/EP2316820A1/en
Application filed filed Critical
Publication of JP2013509376A publication Critical patent/JP2013509376A/ja
Publication of JP2013509376A5 publication Critical patent/JP2013509376A5/ja
Pending legal-status Critical Current

Links

JP2012535821A 2009-10-28 2010-10-28 ブラジキニン受容体アンタゴニストとして有用な２−アリール−プロピオンアミド誘導体およびそれらを含有する医薬組成物 Pending JP2013509376A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09174390.6 2009-10-28
EP09174390A EP2316820A1 (en) 2009-10-28 2009-10-28 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
PCT/EP2010/066324 WO2011051375A1 (en) 2009-10-28 2010-10-28 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
JP2013509376A JP2013509376A (ja) 2013-03-14
JP2013509376A5 true JP2013509376A5 (enExample) 2013-12-19

Family

ID=41559661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535821A Pending JP2013509376A (ja) 2009-10-28 2010-10-28 ブラジキニン受容体アンタゴニストとして有用な２−アリール−プロピオンアミド誘導体およびそれらを含有する医薬組成物

Country Status (8)

Country Link
US (1) US20120316169A1 (enExample)
EP (2) EP2316820A1 (enExample)
JP (1) JP2013509376A (enExample)
KR (1) KR20120084771A (enExample)
CN (1) CN102656140A (enExample)
AU (1) AU2010311466B2 (enExample)
WO (1) WO2011051375A1 (enExample)
ZA (1) ZA201203040B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102701949A (zh) * 2012-06-14 2012-10-03 山东新华制药股份有限公司 2-[4-(2-甲基-1-丙烯基)苯基]丙酸的制备方法
MX2015012650A (es) * 2013-03-14 2016-06-21 Shire Human Genetic Therapies Metodos para el tratamiento de angioedema mediado receptores debradicinina b2.
WO2019046668A1 (en) * 2017-08-31 2019-03-07 Kezar Life Sciences AMIDE-SUBSTITUTED THIAZOLES AS INHIBITORS OF SECRETIC PROTEIN
CA3077659A1 (en) * 2017-10-09 2019-04-18 Ramot At Tel-Aviv University Ltd. Modulators of potassium ion and trpv1 channels and uses thereof
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
CA3176715A1 (en) * 2020-03-26 2021-09-30 Dompe' Farmaceutici Spa Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
CN115403483B (zh) * 2021-07-02 2024-01-26 河南省儿童医院郑州儿童医院 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
CN120093725B (zh) * 2025-03-13 2025-12-16 江西中医药大学附属医院 金发藓酮e在制备治疗糖尿病视网膜病变药物中的应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE764238A (fr) * 1971-03-17 1971-09-13 Lilly Industries Ltd Derives de phenylalkylamine
JPS6023105B2 (ja) * 1982-10-22 1985-06-05 八洲化学工業株式会社 α，α−ジメチルフエニル酢酸アニリド誘導体、その製造法及びそれを含有する除草剤
TW253885B (enExample) * 1992-12-15 1995-08-11 Ishihara Sangyo Kaisha
JPH06234763A (ja) * 1992-12-15 1994-08-23 Ishihara Sangyo Kaisha Ltd 環状アミド系化合物、それらの製造方法及びそれらを含有する除草性組成物
AU687202B2 (en) * 1994-05-31 1998-02-19 Teijin Limited Naphthalene derivative
FR2743562B1 (fr) 1996-01-11 1998-04-03 Sanofi Sa Derives de n-(arylsulfonyl) aminoacides, leur preparation, les compositions pharmaceutiques en contenant
GB9702194D0 (en) * 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
JP3752854B2 (ja) * 1998-07-15 2006-03-08 宇部興産株式会社 Ｎ−ベンジルカルバメイト化合物、その製法及び農園芸用の殺菌剤
CZ20012350A3 (cs) * 1998-12-24 2001-09-12 Aventis Pharmaceuticals Products Inc. Substituované (aminoiminomethyl nebo aminomethyl) benzoheteroarylové sloučeniny
GB9913079D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
JP2003505384A (ja) 1999-07-15 2003-02-12 ファーマコピーア，インコーポレーティッド ブラジキニンｂ１受容体アンタゴニスト
ITMI20010395A1 (it) * 2001-02-27 2002-08-27 Dompe Spa Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate
BR0209386A (pt) 2001-05-14 2004-07-06 Novartis Ag Derivados de sulfonamida
AU2002346048A1 (en) 2001-06-07 2002-12-16 Merck And Co., Inc. Benzodiazepine bradykinin antagonists
DE10134721A1 (de) 2001-07-17 2003-02-06 Bayer Ag Tetrahydrochinoxaline
AR036375A1 (es) * 2001-08-30 2004-09-01 Novartis Ag Compuestos pirrolo [2,3-d] pirimidina -2- carbonitrilo, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de medicamentos
EP1501807A1 (en) 2002-05-03 2005-02-02 Elan Pharmaceuticals, Inc. Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
FR2840897B1 (fr) 2002-06-14 2004-09-10 Fournier Lab Sa Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
US20040034064A1 (en) 2002-08-06 2004-02-19 Kuduk Scott D. 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives
US20040063761A1 (en) 2002-08-06 2004-04-01 Kuduk Scott D. 2-(biarylalkyl)amino-3-(fluoroalkanoylamino)pyridine derivatives
US20040029920A1 (en) 2002-08-06 2004-02-12 Kuduk Scott D. 2-(biarylalkyl)amino-3-(heterocyclylcarbonylamino)-pyridine derivatives
US6908921B2 (en) 2002-12-13 2005-06-21 Merck & Co., Inc. Quinoxalinone derivatives as bradykinin B1 antagonists
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
KR100707123B1 (ko) * 2003-07-02 2007-04-16 그뤼넨탈 게엠베하 바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
RU2375346C2 (ru) * 2003-09-25 2009-12-10 ДОМПЕ ФА.Р.МА С.п.А. Амидины и их производные и содержащие их фармацевтические композиции
US20050171172A1 (en) * 2003-11-13 2005-08-04 Ambit Biosciences Corporation Amide derivatives as PDGFR modulators
JP2005170939A (ja) * 2003-11-20 2005-06-30 Takeda Chem Ind Ltd 糖尿病の予防・治療剤
PT1776336E (pt) * 2004-03-23 2009-12-18 Dompe Spa Derivados de ácido 2-fenilpropiónico e composições farmacêuticas que os contêm
CN1984933A (zh) 2004-07-09 2007-06-20 三井化学株式会社 热塑性树脂
EP1833836B1 (en) * 2004-11-12 2011-12-21 Bristol-Myers Squibb Company Imidazo-fused thiazolo [4,5-b] pyridine based tricyclic compounds and pharmaceutical compositions comprising same
US20060111392A1 (en) * 2004-11-23 2006-05-25 Wood Michael R Substituted biaryl-carboxylate derivatives
DE602005013001D1 (de) * 2004-12-15 2009-04-09 Dompe Pha R Ma Spa Res & Mfg 2-arylpropionsäurederivate und pharmazeutische zusammensetzungen, die diese enthalten
TW200715993A (en) * 2005-06-15 2007-05-01 Senomyx Inc Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
PT2094638E (pt) * 2006-12-19 2012-11-20 Dompe Spa Ácidos 2-aril-fluoropropanóicos e derivados e composições farmacêuticas que os contêm
WO2009001127A1 (en) * 2007-06-26 2008-12-31 Astrazeneca Ab Cyanocyclopropylcarboxamides as cathepsin inhibitors
US20110166132A1 (en) * 2007-12-13 2011-07-07 Amgen Inc. Gamma Secretase Modulators
AR076752A1 (es) * 2009-05-07 2011-07-06 Gruenenthal Chemie Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides.

Similar Documents

Publication Publication Date Title
JP2013509376A5 (enExample)
TWI409261B (zh) 經取代之苯甲醯胺衍生物
KR101167773B1 (ko) Ｔａａｒ１ 리간드로서의 피리딘카복스아마이드 및 벤즈아마이드 유도체
KR101461294B1 (ko) Ｃｎｓ 장애 치료용 옥사졸린 유도체
JP2015509543A5 (enExample)
JP2012515209A5 (enExample)
JP2015517981A5 (enExample)
KR20130036093A (ko) 화합물 및 방법
JP6183451B2 (ja) ２−アシルアミノチアゾール誘導体またはその塩
JP2007519754A5 (enExample)
JP2010520876A (ja) ピペラジンおよびピペリジンｍＧｌｕＲ５増強剤
EP1302463A1 (en) Medicine comprising dicyanopyridine derivative
JP2013530240A5 (enExample)
CN1341101A (zh) 苯基一和吡啶基衍生物
JP6319436B2 (ja) ２−アシルアミノチアゾール誘導体またはその塩
JP2013507449A5 (enExample)
JPWO2014098098A1 (ja) 複素環アミド誘導体及びそれを含有する医薬
PT2041093E (pt) Derivados de piperazinilo úteis no tratamento de doenças mediadas pelo receptor gpr38
JP2010501587A5 (enExample)
JP2012500783A5 (enExample)
JP2010540462A5 (enExample)
TW200922582A (en) N-benzyl, N'-arylcarbonylpiperazine derivatives
JP2006525299A5 (enExample)
CA2688267A1 (en) Amino acid derivatives as calcium channel blockers
CA2977837A1 (en) Ghrelin o-acyl transferase inhibitors